Belladonna / ergotamine / phenobarbital Drug Interactions
A total of 1406 drugs (8329 brand and generic names) are known to interact with belladonna / ergotamine / phenobarbital.
- 623 major drug interactions (4484 brand and generic names)
- 729 moderate drug interactions (3643 brand and generic names)
- 54 minor drug interactions (202 brand and generic names)
Check for interactions with belladonna / ergotamine / phenobarbital
Common medications checked in combination with belladonna / ergotamine / phenobarbital
- Bystolic (nebivolol)
- Cymbalta (duloxetine)
- Lasix (furosemide)
- Lipitor (atorvastatin)
- Lyrica (pregabalin)
- Norco (acetaminophen / hydrocodone)
- Pepcid (famotidine)
- Plavix (clopidogrel)
- Protonix (pantoprazole)
- Reglan (metoclopramide)
- Synthroid (levothyroxine)
- Vitamin D2 (ergocalciferol)
- Xanax (alprazolam)
- Zofran (ondansetron)
belladonna / ergotamine / phenobarbital alcohol/food Interactions
There are 6 alcohol/food interactions with belladonna / ergotamine / phenobarbital
belladonna / ergotamine / phenobarbital disease Interactions
There are 35 disease interactions with belladonna / ergotamine / phenobarbital which include:
- Autonomic Neuropathy
- Gi Obstruction
- Glaucoma
- Obstructive Uropathy
- Reactive Airway Diseases
- Myasthenia Gravis
- Infectious Diarrhea
- Acute Alcohol Intoxication
- Drug Dependence
- Liver Disease
- Porphyria
- Rash
- Respiratory Depression
- Cardiovascular
- Prolonged Hypotension
- Vasospastic Reactions
- Renal Dysfunction
- Cardiac Disease
- Tachycardia
- Suicidal Tendency
- Coronary Artery Disease
- Gastric Ulcer
- Gastroesophageal Reflux
- Ulcerative Colitis
- Liver Disease
- Renal Failure
- Adrenal Insufficiency
- Depression
- Hematologic Toxicity
- Osteomalacia
- Paradoxical Reactions
- Hypertension
- Hyperthyroidism
- Diarrhea
- Fever
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
